Breast Cancer Prevention (PDQ®)–Health Professional Version

SECTIONS

Changes to This Summary (03/29/2018)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Description of the Evidence

Updated statistics with estimated new cases and deaths for 2018 (cited American Cancer Society as reference 1).

Revised text to state that breast cancer incidence rates increased slightly in black women by 0.3% per year between 2005 and 2014, resulting in the convergence of rates in blacks with those in whites.

Added text to state that family history and mutation location within the BRCA1 or BRCA2gene may contribute to the risk of cancer development among those with an inherited predisposition to breast cancer (cited Kuchenbaecker et al. as reference 28).

Added text about a nationwide prospective cohort study in Denmark that found that women who currently or recently used contemporary hormonal contraceptives had a higher risk of breast cancer than did women who had never used hormonal contraceptives; however, in absolute terms, the effect of oral contraceptives on breast cancer risk was very small (cited Mørch et al. as reference 128).

This summary is written and maintained by the PDQ Screening and Prevention Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.

< Previous section
Description of the Evidence

Next section >
About This PDQ Summary

Breast Cancer Prevention (PDQ®)—Health Professional Version - National Cancer Institute